Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
GT Biopharma, Inc. (GTBP) had Weighted-Average Shares Outstanding (Diluted) of 2.35M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-0.78M |
|
-- |
|
-- |
|
$1.93M |
|
$-1.93M |
|
$1.16M |
|
$-0.78M |
|
$-0.78M |
|
$-0.78M |
|
$-0.78M |
|
$-0.78M |
|
$-0.78M |
|
$-1.93M |
|
$-1.93M |
|
2.35M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
2.35M |
$-0.33 |
|
$-0.33 |
|
| Balance Sheet Financials | |
$2.66M |
|
-- |
|
-- |
|
$2.66M |
|
$3.64M |
|
-- |
|
-- |
|
$3.64M |
|
$-0.98M |
|
$-0.98M |
|
$-0.98M |
|
2.54M |
|
| Cash Flow Statement Financials | |
$-2.20M |
|
-- |
|
$0.62M |
|
$4.04M |
|
$2.46M |
|
$-1.59M |
|
$0.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.73 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.20M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
79.10% |
|
79.18% |
|
-29.19% |
|
79.18% |
|
$-0.39 |
|
$-0.94 |
|
$-0.94 |
|